Evidence map›Paper›PMID 40500747›Full record

ArticleBioData mining2025

A probabilistic approach for building disease phenotypes across electronic health records.

David Vidmar, Jessica De Freitas, Will Thompson, John M Pfeifer, Brandon K Fornwalt, Noah Zimmerman, Riccardo Miotto, Ruijun Chen

Abstract read
In one paragraph

Article in BioData mining, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

David VidmarTempus AI, 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA. david.vidmar@tempus.com.
Jessica De FreitasTempus AI, 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA.
Will ThompsonTempus AI, 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA.
John M PfeiferTempus AI, 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA.
Brandon K FornwaltTempus AI, 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA.
Noah ZimmermanTempus AI, 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA.
Riccardo MiottoTempus AI, 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA.
Ruijun ChenTempus AI, 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentifying the set of patients with a particular disease diagnosis across electronic health records (EHRs), referred to as a phenotype, is an important step in clinical research and applications. However, this task is often challenging, where incomplete data can render definitive classifications impossible. We propose a probabilistic approach to phenotyping based on Bayesian inference and without the need for gold-standard labels. In this paper, we develop multiple heuristic “labeling functions’’ (LFs) for 4 diseases across de-identified EHR data and aggregate their votes through a majority vote approach (MV), a popular open-source approach (Snorkel OSS), and our proposed probabilistic approach (LEVI). We compare the resulting phenotypes to those built using expert-curated logic from the literature, as well as an off-the-shelf natural language processing pipeline (Medspacy), using a curated sample of physician-reviewed labels for evaluation.

resultsPhenotypes built using LFs perform better than off-the-shelf alternatives on classification performance (F1 scores of 0.79–0.82 vs. expert-logic: 0.68, Medspacy: 0.55). Compared to output scores from Snorkel OSS, LEVI provides better probabilistic performance (expected calibration error of 0.04 vs. 0.12), ROC AUC estimates (interval score [loss] of 0.03 vs. 0.10), and operating point selection (equal-cost net benefit of 0.18 vs. 0.15).

conclusionsFor challenging disease states, phenotyping using probabilities rather than binary classification can lead to improved and more personalized downstream decision-making. Probabilistic phenotypes built using LEVI exhibit low calibration error without the need for labels, allowing for better risk-benefit tradeoffs.

Indexed as

Bayesian inferenceDecision theoryEHR phenotypingModel calibrationWeak supervision

Identifiers

PMID40500747
PMCPMC12153169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.